There is some value to communication between doctors and the companies that make medicines.
Lowering prices abroad to make medicines affordable to a broader swath of the population has resulted in higher emerging market sales.
Also sitting pretty is Nexia, particularly since it began to focus on the use of transgenic animals to make medicines that can protect against nerve agents.
Those growing doubts are going to make medicines even harder to get past regulators, and then they are going to make them more difficult to market to doctors.
Professor Venter said it is the only way drug companies are going to use genetic information to make medicines - to invest in the research they need the patent protection to ensure they recoup their money.
Novartis Chief Executive Daniel Vasella has argued that although branded prescription medicines are sold at much higher prices, a worldwide emphasis on cost-savings make copycat medicines a fast-growing market worth being in.
The New York-based drug giant will make its medicines available to all of those 43 million people at a discount--and sometimes for free.
While drug costs are the main focus of discussion and debate, Zook points out that companies do a great deal to make their medicines available to those who cannot afford them.
However, this would be government stepping in to artificially keep prices high simply because the drug companies accept no responsibility to make these medicines available once they no longer hold the promise of the giant profits they once presented.
For one thing, it signals that these companies are finding ways of using these new technologies to make their medicines more effective --making for better odds in getting Food and Drug Administration approval and reducing money wasted testing drugs that won't work in human beings.
In order to make sure that medicines are safe, we need to find new ways to track existing drugs.
As long as that attitude is pervasive, the high price of prescription drugs is likely to remain a problem for drugmakers, who are baffled that they are nearly as reviled as tobacco companies even though they make life saving medicines.
Want to make sure that new medicines reach the market as quickly as possible?
But right now it seems unlikely that these new medicines will make up for the losses ahead.
These new powers may increase the number of medicines that make it to market through the regulatory gauntlet, too.
Even slight advantages over other medicines can make a drug into a blockbuster.
One big hope is Zetia, a cholesterol pill that would be added onto other cholesterol-lowering medicines to make them stronger.
Stockpiles of disease control equipment, anti-viral drugs and clinical equipment have been increased and China says it has the capacity to make anti-viral medicines.
As long as we do that, we'll be able to recruit the world-class people who want to come to industry to do important work to translate basic science into medicines that make a difference to human beings.
Like many maternity clinics in rural parts of Africa, the health center in Atitiri is lacking several necessary resources -- shortage of running water, electricity challenges, broken beds and scarcity of medicines all make Madudu's job very difficult.
CNN: Campaign to nominate African midwife for Nobel Peace Prize
In the long term, though, such a deal is probably a bad idea, one of those short-term fixes that has left drug companies scrambling to reinvigorate their research labs as fewer and fewer medicines actually make it to patients.
Knowing less about Pfizer s smaller medicines will only make it harder for tiny biotech firms that are trying to compete with it.
Worries about emerging side effects may also be slowing sales growth for the medicines that eventually make it through the regulatory maze.
Getting the most out of medicines that do make it to market will require better relationships with health insurers, something D'Amelio, who has served on the board of insurer Humana, may also be able to help with.
Getting the most out of medicines that do make it to market will require better relationships with health insurers, something D'Amelio, who has served on the board of insurer Humana (nyse: HUM - news - people ), may also be able to help with.
Individual physicians make names for themselves by analyzing medicines and writing scientific papers.
In most Chinese hospitals, their share of profits from the sale of medicines is supposed to make up for this.
Christie Ballantyne of Houston's Baylor College of Medicine says he thinks using resin drugs like Questran or WelChol before Zetia doesn't make much sense, because those medicines are so inconvenient that patients won't stay on them.
It's where drug companies make most of their money on branded medicines.
应用推荐